+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 1
Age: 18Years - 80Years
All Genders
Healthy Volunteers
ID07916181

Study of Intravenous Fosmanogepix Pharmacokinetics and Safety in Adults With End-stage Renal Disease on Hemodialysis Compared to Healthy Adults

Led by Basilea Pharmaceutica · Updated on 2026-11-04

20

Participants Needed

2

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating how the investigational drug fosmanogepix is processed in the body of adults with severe kidney failure requiring intermittent hemodialysis compared to adults with normal kidney function. The study aims to understand the pharmacokinetics of fosmanogepix, which is given intravenously and converted in the body to its active form, manogepix. The trial also assesses how hemodialysis affects drug levels and evaluates the drugs safety and tolerability in these groups. Participants with end-stage renal disease on hemodialysis will receive intravenous fosmanogepix in two separate study periods, each involving two doses on consecutive days. Healthy participants with normal kidney function will receive the drug in one study period with the same dosing schedule. The study is conducted at two sites in the United States and lasts up to 11 weeks, including all study periods. During the study, participants undergo multiple blood samplings to measure drug concentrations at specified days in each period. Safety monitoring includes recording any adverse events up to 35 days after the last drug dose. Researchers will analyze maximum plasma concentration, area under the curve, and the impact of hemodialysis on drug levels. The study provides close observation and data collection to understand how the drug behaves and is tolerated in participants with and without kidney failure.

CONDITIONS

Brief Title

A Study to Test the Safety of the Study Drug Fosmanogepix and How the Body Handles It in Adults With Severe Kidney Failure on Dialysis

Research Team

T

Thomas Kaindl, MD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here